PMDA
- Application: Erelsa
- Local brand name: Erelsa
- Status: approved
🇯🇵 Zepatier in Japan
Zepatier (ELBASVIR) regulatory status in Japan.
Marketing authorisation
Zepatier in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Japan
Frequently asked questions
Is Zepatier approved in Japan?
Yes. PMDA has authorised it.
Who is the marketing authorisation holder for Zepatier in Japan?
Merck & Co. is the originator. The local marketing authorisation holder may differ — check the official source linked above.